Pioglitazone-associated fulminant hepatic failure.
Chase
Michael P
MP
Yarze
Joseph C
JC
D000368:Aged; D001707:Biopsy, Needle; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D005500:Follow-Up Studies; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D017093:Liver Failure / Q000139:chemically induced* / Q000175:diagnosis; D008111:Liver Function Tests; D008297:Male; D000077205:Pioglitazone; D018570:Risk Assessment; D013844:Thiazoles / Q000009:adverse effects* / Q000627:therapeutic use; D045162:Thiazolidinediones
D007004:Hypoglycemic Agents; D013844:Thiazoles; D045162:Thiazolidinediones; D000077205:Pioglitazone